General Practitioner since 1981. Post graduate qualifications include Fellowships of both Australian and New Zealand Royal Colleges of General Practitioners. Medical Director of a primary health care based clinical trials unit since 2007. Second unit established in 2010. Experienced Principal Investigator with a wide range of phase 1B - 4 clinical trials. Trials included Covid-19, RSV, influenza, pneumococcal and HPV vaccine studies, hyperlipidaemia, diabetes, immune response, migraine, soft tissue injuries, COPD, asthma, atopic dermatitis, type 2 diabetes, urticaria, aging, gout, endometriosis, cardiovascular outcomes, pain, sleep disorders, obesity, osteoarthritis, low libido and depression. Established SCT Group Ltd with Julia Mathieson in 2011. SCTG established 6 Clinical Trial sites around NZ and became part of a large NZ/Australian network called Pacific Clinical Research Network (PCRN). With the formal merger of SCTG with Lakeland Clinical Trials Group (LCTG) to form PCRN NZ and the investment by Pencarrow Private Equity Simon took on the role of Medical Advisor for PCRN NZ. Formerly Associate Professor of Family and Community Health. Specialties: Phase 2 - 4 clinical trials.Maintains an active interest with a role on the PCRN Founders’ Advisory Board.